FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Thomas Sudhop

Research Profile

Chemicals & Drugs

Concepts & Ideas

Anatomy

Livers

Co-author Network

Publications

TOP 3
Heiner K Berthold; Thomas Sudhop; Klaus Von Bergmann; Ioanna Gouni-Berthold
Lifibrol as a model compound for a novel lipid-lowering mechanism of action.
Heiner K. Berthold; Jessica Mertens; Julia Birnbaum; Susanne Brämswig; Thomas Sudhop; P Hugh R Barrett; Klaus Von Bergmann; Ioanna Gouni-Berthold
Influence of simvastatin on apoB-100 secretion in non-obese subjects with mild hypercholesterolemia.
Thomas Sudhop; Michael Reber; Diane L Tribble; Aditi Sapre; William Taggart; Patrice Gibbons; Thomas Musliner; Klaus Von Bergmann; Dieter Lütjohann
Changes in cholesterol absorption and cholesterol synthesis caused by ezetimibe and/or simvastatin in men.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Thomas Sudhop (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Heiner K Berthold; Thomas Sudhop; Klaus Von Bergmann; Ioanna Gouni-Berthold
Lifibrol as a model compound for a novel lipid-lowering mechanism of action.
Journal of cardiovascular pharmacology and therapeutics 2010;15(4):364-72.
2010: Heiner K. Berthold; Jessica Mertens; Julia Birnbaum; Susanne Brämswig; Thomas Sudhop; P Hugh R Barrett; Klaus Von Bergmann; Ioanna Gouni-Berthold
Influence of simvastatin on apoB-100 secretion in non-obese subjects with mild hypercholesterolemia.
Lipids 2010;45(6):491-500.
2009: Thomas Sudhop; Michael Reber; Diane L Tribble; Aditi Sapre; William Taggart; Patrice Gibbons; Thomas Musliner; Klaus Von Bergmann; Dieter Lütjohann
Changes in cholesterol absorption and cholesterol synthesis caused by ezetimibe and/or simvastatin in men.
Journal of lipid research 2009;50(10):2117-23.
2009: Martin Vogel; Norbert Bertram; Jan-Christian Wasmuth; Christoph Wyen; Esther Voigt; Carolynne Schwarze-Zander; Thomas Sudhop; Gerd Fätkenheuer; Jürgen K Rockstroh; Christoph Reichel
Nevirapine pharmacokinetics in HIV-infected and HIV/HCV-coinfected individuals.
The Journal of antimicrobial chemotherapy 2009;63(5):988-91.
2008: Oliver Weingärtner; Dieter Lütjohann; Shengbo Ji; Nicole Weisshoff; Franka List; Thomas Sudhop; Klaus Von Bergmann; Karen Gertz; Jochem König; Hans-Joachim Schäfers; Matthias Endres; Michael Böhm; Ulrich Laufs
Vascular effects of diet supplementation with plant sterols.
Journal of the American College of Cardiology 2008;51(16):1553-61.
2007: C Knabe; Thomas Sudhop; Klaus Von Bergmann; Dieter Lütjohann
Degradation of 24S-hydroxycholesterol in men is not regulated by CYP7A1.
International journal of clinical pharmacology and therapeutics 2007;45(11):577-82.
2006: Jacob J Clarenbach; Michael Reber; Dieter Lütjohann; Klaus Von Bergmann; Thomas Sudhop
The lipid-lowering effect of ezetimibe in pure vegetarians.
Journal of lipid research 2006;47(12):2820-4.
2006: Thomas Gerloff; Melanie Schaefer; Jessica Mwinyi; Andreas Johne; Thomas Sudhop; Dieter Lütjohann; Ivar Roots; Klaus Von Bergmann
Influence of the SLCO1B1*1b and *5 haplotypes on pravastatin's cholesterol lowering capabilities and basal sterol serum levels.
Naunyn-Schmiedeberg's archives of pharmacology 2006;373(1):45-50.
2006: Stefan Oswald; Sierk Haenisch; Christiane Fricke; Thomas Sudhop; Cornelia Remmler; Thomas Giessmann; Gabriele Jedlitschky; Ulrike Adam; Eike Dazert; Rolf Warzok; Wolfram Wacke; Ingolf Cascorbi; Heyo K Kroemer; Werner Weitschies; Klaus Von Bergmann; Werner Siegmund
Intestinal expression of P-glycoprotein (ABCB1), multidrug resistance associated protein 2 (ABCC2), and uridine diphosphate-glucuronosyltransferase 1A1 predicts the disposition and modulates the effects of the cholesterol absorption inhibitor ezetimibe in humans.
Clinical pharmacology and therapeutics 2006;79(3):206-17.
2005: Lily Jakulj; Mieke D Trip; Thomas Sudhop; Klaus Von Bergmann; John J P Kastelein; Maud N Vissers
Inhibition of cholesterol absorption by the combination of dietary plant sterols and ezetimibe: effects on plasma lipid levels.
Journal of lipid research 2005;46(12):2692-8.
2005: Klaus Von Bergmann; Thomas Sudhop; Dieter Lütjohann
Cholesterol and plant sterol absorption: recent insights.
The American journal of cardiology 2005;96(1A):10D-14D.
2005: S C Thuluva; Michael Igel; Uwe Giesa; Dieter Lütjohann; Thomas Sudhop; Klaus Von Bergmann
Ratio of lathosterol to campesterol in serum predicts the cholesterol-lowering effect of sitostanol-supplemented margarine.
International journal of clinical pharmacology and therapeutics 2005;43(7):305-10.
2005: Thomas Sudhop; Dieter Lütjohann; Klaus Von Bergmann
Sterol transporters: targets of natural sterols and new lipid lowering drugs.
Pharmacology & therapeutics 2005;105(3):333-41.
2004: Thomas Sudhop; Klaus Von Bergmann
Sitosterolemia--a rare disease. Are elevated plant sterols an additional risk factor?
Zeitschrift für Kardiologie 2004;93(12):921-8.
2004: Martin Vogel; Esther Voigt; Hans-Christoph Michaelis; Thomas Sudhop; Martin Wolff; Andreas Türler; Tilman Sauerbruch; Jürgen K Rockstroh; Ulrich Spengler
Management of drug-to-drug interactions between cyclosporine A and the protease-inhibitor lopinavir/ritonavir in liver-transplanted HIV-infected patients.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2004;10(7):939-44.
2004: Dieter Lütjohann; C Hahn; Wolfgang Prange; Thomas Sudhop; M Axelson; Tilman Sauerbruch; Klaus Von Bergmann; Christoph Reichel
Influence of rifampin on serum markers of cholesterol and bile acid synthesis in men.
International journal of clinical pharmacology and therapeutics 2004;42(6):307-13.
2004: Tanja Weinbrenner; M Züger; Georg E Jacoby; S Herpertz; Reinhard Liedtke; Thomas Sudhop; Ioanna Gouni-Berthold; M Axelson; Heiner K. Berthold
Lipoprotein metabolism in patients with anorexia nervosa: a case-control study investigating the mechanisms leading to hypercholesterolaemia.
The British journal of nutrition 2004;91(6):959-69.
2003: Arina Igel-Korcagova; Peter Raab; Karl August Brensing; Uwe Pöge; Hans-Ulrich Klehr; Michael Igel; Klaus Von Bergmann; Thomas Sudhop
Cholesterol metabolism in patients with chronic renal failure on hemodialysis.
Journal of nephrology 2003;16(6):850-4.
2003: Thomas Sudhop; K von Bergmann
[Coronary disease prevention: only the inhibition of inflammation is important. Why lower lipids, too?].
MMW Fortschritte der Medizin 2003;145(21):19.
2003: Michael Schepke; Felix Roth; Rolf Fimmers; Karl August Brensing; Thomas Sudhop; Hans H Schild; Tilman Sauerbruch
Comparison of MELD, Child-Pugh, and Emory model for the prediction of survival in patients undergoing transjugular intrahepatic portosystemic shunting.
The American journal of gastroenterology 2003;98(5):1167-74.
2003: Thomas Sudhop; Klaus Von Bergmann
[Ezetimib as combination partner in hypercholesteremia. Lowering LDL beyond the effect of statins].
MMW Fortschritte der Medizin 2003;145(16):48-50.
2003: Susanne Brämswig; Thomas Sudhop; Claus Luers; Klaus Von Bergmann; Heiner K. Berthold
Lipoprotein(a) concentration increases during treatment with carbamazepine.
Epilepsia 2003;44(3):457-60.
2003: Thomas Sudhop; Dieter Lütjohann; Mohamed Agna; Claudia von Ameln; Wolfgang Prange; Klaus Von Bergmann
Comparison of the effects of sitostanol, sitostanol acetate, and sitostanol oleate on the inhibition of cholesterol absorption in normolipemic healthy male volunteers. A placebo controlled randomized cross-over study.
Arzneimittel-Forschung 2003;53(10):708-13.
2003: Michael Igel; Thomas Sudhop; Klaus Von Bergmann
[Pleiotrophic effect of statins (3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors)].
Arzneimittel-Forschung 2003;53(8):545-53.
2002: Jan-Christian Wasmuth; Kirsten Schliefer; Christian Scheurlen; Thomas Sudhop; Jürgen K Rockstroh; Tilman Sauerbruch; Ulrich Spengler
Enteric dysfunction in patients with asymptomatic HIV-infection versus patients with hypoproteinemia/hypalbuminemia and advanced HIV-infection.
European journal of medical research 2002;7(12):536-42.
2002: Thomas Sudhop; Britta M Gottwald; Klaus Von Bergmann
Serum plant sterols as a potential risk factor for coronary heart disease.
Metabolism: clinical and experimental 2002;51(12):1519-21.
2002: Thomas Sudhop; Y Sahin; Bernhard Lindenthal; C Hahn; C Lüers; Heiner K. Berthold; Klaus Von Bergmann
Comparison of the hepatic clearances of campesterol, sitosterol, and cholesterol in healthy subjects suggests that efflux transporters controlling intestinal sterol absorption also regulate biliary secretion.
Gut 2002;51(6):860-3.
2002: Thomas Sudhop; Dieter Lütjohann; Annette Kodal; Michael Igel; Diane L Tribble; Sukrut Shah; Inna Perevozskaya; Klaus Von Bergmann
Inhibition of intestinal cholesterol absorption by ezetimibe in humans.
Circulation 2002;106(15):1943-8.
2002: Harald Schäfer; Dirk Pauleit; Thomas Sudhop; Ioanna Gouni-Berthold; Santiago Ewig; Heiner K. Berthold
Body fat distribution, serum leptin, and cardiovascular risk factors in men with obstructive sleep apnea.
Chest 2002;122(3):829-39.
2002: Michael Igel; Thomas Sudhop; Klaus Von Bergmann
Pharmacology of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins), including rosuvastatin and pitavastatin.
Journal of clinical pharmacology 2002;42(8):835-45.
2002: Karl August Brensing; Peter Raab; Jochen Textor; Johannes Görich; Peter Schiedermaier; Holger Strunk; Dieter Paar; Michael Schepke; Thomas Sudhop; Ulrich Spengler; Hans Schild; Tilman Sauerbruch
Prospective evaluation of a clinical score for 60-day mortality after transjugular intrahepatic portosystemic stent-shunt: Bonn TIPSS early mortality analysis.
European journal of gastroenterology & hepatology 2002;14(7):723-31.
2002: Bernhard Lindenthal; Thomas Sudhop; Peter Schiedermaier; Mohamed Agnan; Tilman Sauerbruch; Klaus Von Bergmann
Serum plant sterols and biliary cholesterol secretion in humans: studies with ursodeoxycholic acid.
Journal of lipid research 2002;43(7):1072-7.
2002: Bernhard Lindenthal; TA Aldaghlas; AL Holleran; Thomas Sudhop; Heiner K. Berthold; Klaus Von Bergmann; Joanne K Kelleher
Isotopomer spectral analysis of intermediates of cholesterol synthesis in human subjects and hepatic cells.
American journal of physiology. Endocrinology and metabolism 2002;282(6):E1222-30.
2002: Susanne Brämswig; Anja Kerksiek; Thomas Sudhop; Claus Luers; Klaus Von Bergmann; Heiner K. Berthold
Carbamazepine increases atherogenic lipoproteins: mechanism of action in male adults.
American journal of physiology. Heart and circulatory physiology 2002;282(2):H704-16.
2002: Thomas Sudhop; Klaus Von Bergmann
Cholesterol absorption inhibitors for the treatment of hypercholesterolaemia.
Drugs 2002;62(16):2333-47.
2002: Armin Zittermann; J Rühl; Heiner K. Berthold; Thomas Sudhop; Hans van der Ven; Jochen Reinsberg; Peter Stehle
Oral contraceptives moderately effect bone resorption markers and serum-soluble interleukin-6 receptor concentrations.
Calcified tissue international 2002;70(1):11-21.
2001: Michael Igel; Thomas Sudhop; Klaus Von Bergmann
Metabolism and drug interactions of 3-hydroxy-3-methylglutaryl coenzyme A-reductase inhibitors (statins).
European journal of clinical pharmacology 2001;57(5):357-64.
2001: K von Bergmann; P Laeis; K Püchler; Thomas Sudhop; L R Schwocho; L Gonzalez
Olmesartan medoxomil: influence of age, renal and hepatic function on the pharmacokinetics of olmesartan medoxomil.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 2001;19(1):S33-40.
2000: Christoph Reichel; Thomas Sudhop; B Braun; Karl-Anton Kreuzer; C Hahn; MP Look; Klaus Von Bergmann; Tilman Sauerbruch; Ulrich Spengler
Elevated soluble tumour necrosis factor receptor serum concentrations and short-term mortality in liver cirrhosis without acute infections.
Digestion 2000;62(1):44-51.
2000: Armin Zittermann; I Schwarz; K Scheld; Thomas Sudhop; Heiner K. Berthold; K von Bergmann; Hans van der Ven; Peter Stehle
Physiologic fluctuations of serum estradiol levels influence biochemical markers of bone resorption in young women.
The Journal of clinical endocrinology and metabolism 2000;85(1):95-101.
1999: MP Look; A Gerard; GS Rao; Thomas Sudhop; Hans-Peter Fischer; Tilman Sauerbruch; Ulrich Spengler
Interferon/antioxidant combination therapy for chronic hepatitis C--a controlled pilot trial.
Antiviral research 1999;43(2):113-22.
1999: Thomas Sudhop; Jan Bauer; Christian E Elger; Klaus Von Bergmann
Increased high-density lipoprotein cholesterol in patients with epilepsy treated with carbamazepine: a gender-related study.
Epilepsia 1999;40(4):480-4.
1999: Claus Luers; Thomas Sudhop; U Spengler; Heiner K. Berthold
Improvement of sarcoidosis under therapy with interferon-alpha 2b for chronic hepatitis B virus infection.
Journal of hepatology 1999;30(2):347.
1998: Heiner K. Berthold; Thomas Sudhop
Garlic preparations for prevention of atherosclerosis.
Current opinion in lipidology 1998;9(6):565-9.
1998: Heiner K. Berthold; Thomas Sudhop; K von Bergmann
Effect of a garlic oil preparation on serum lipoproteins and cholesterol metabolism: a randomized controlled trial.
JAMA : the journal of the American Medical Association 1998;279(23):1900-2.
1998: Jürgen K Rockstroh; Rainer P Woitas; Hans H Brackmann; Bernd Kupfer; Rolf Kaiser; Karl-Eduard Schneweis; Thomas Sudhop; Ulrich Spengler
In vitro cytopathogenicity of the human immunodeficiency virus (HIV)-1 predicts survival in HIV-infected hemophiliacs independent from CD4 cell count.
European journal of medical research 1998;3(5):223-30.
1998: MP Look; Jürgen K Rockstroh; GS Rao; S Barton; H Lemoch; R Kaiser; Bernd Kupfer; Thomas Sudhop; Ulrich Spengler; Tilman Sauerbruch
Sodium selenite and N-acetylcysteine in antiretroviral-naive HIV-1-infected patients: a randomized, controlled pilot study.
European journal of clinical investigation 1998;28(5):389-97.
1997: Christoph Reichel; A Nacke; Thomas Sudhop; G Wienkoop; C Lüers; C Hahn; C Pohl; Ulrich Spengler; Tilman Sauerbruch
The low-dose monoethylglycinexylidide test: assessment of liver function with fewer side effects.
Hepatology (Baltimore, Md.) 1997;25(6):1323-7.
1997: MP Look; Jürgen K Rockstroh; GS Rao; Karl-Anton Kreuzer; S Barton; H Lemoch; Thomas Sudhop; J Hoch; K Stockinger; Ulrich Spengler; Tilman Sauerbruch
Serum selenium, plasma glutathione (GSH) and erythrocyte glutathione peroxidase (GSH-Px)-levels in asymptomatic versus symptomatic human immunodeficiency virus-1 (HIV-1)-infection.
European journal of clinical nutrition 1997;51(4):266-72.
1996: J K Rockstroh; Ulrich Spengler; Thomas Sudhop; Santiago Ewig; Albert Theisen; U Hammerstein; Erhard Bierhoff; Hans-Peter Fischer; Johannes Oldenburg; Hans H Brackmann; Tilman Sauerbruch
Immunosuppression may lead to progression of hepatitis C virus-associated liver disease in hemophiliacs coinfected with HIV.
The American journal of gastroenterology 1996;91(12):2563-8.
1996: T Breuer; Thomas Sudhop; J Hoch; Tilman Sauerbruch; Peter Malfertheiner
Prevalence of and risk factors for Helicobacter pylori infection in the western part of Germany.
European journal of gastroenterology & hepatology 1996;8(1):47-52.
1996: Thomas Sudhop; Dieter Lütjohann; C Ratman; J von Bergmann; Klaus Von Bergmann
Differences in the response of serum lipoproteins to fenofibrate between women and men with primary hypercholesterolaemia.
European journal of clinical pharmacology 1996;50(5):365-9.
1995: F Grünwald; G Späth; Christian Menzel; L Pavics; Thomas Sudhop; P Liesegang; D Klingmüller; AG Schomburg; Hans-Jürgen Biersack
[Scintigraphy of the parathyroid glands with 99mTc-MIBI].
Medizinische Klinik (Munich, Germany : 1983) 1995;90(8):450-5.
1995: Christoph Reichel; G Wienkoop; A Nacke; Thomas Sudhop; Ulrich Spengler; Tilman Sauerbruch
Which lidocaine dose should be used for the MEGX liver function test?
Journal of hepatology 1995;22(5):600.